PropertyValue
?:abstract
  • INTRODUCTION: Adipose-derived stromal cells (ADSCs) can be an important alternative in COVID-19 prevention, treatment, and subsequent sequelae repair. However, ACE-2 plays a common role in the pathogenesis of adipocyte hypertrophy and COVID 19. AREAS COVERED: In this \'Perspective,\' the author would like to emphasize the use of adipose tissue-derived stromal cells in COVID 19 and the issues that clinicians should pay attention to in fat graft applications in terms of adipose tissue-RAS relationship. The new normal for adipose tissue in COVID 19 will be highlighted. EXPERT OPINION: ADSCs may potentially be used in COVID-19. However, it has been speculated that ACE2 receptors are responsible for the pathogenesis of adipose tissue overgrowth and may be a potential danger in terms of the relationship between ACE2 receptors and COVID19. We speculate that reducing the size of overgrown fat tissue by ultra-sharp blades and using near-normal adipocytes will create a \'new normal.\'
?:creator
?:journal
  • Expert_Opin_Biol_Ther
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • New normal: two aspects of adipose tissue in COVID-19-treat and threat?
?:type
?:who_covidence_id
  • #759807
  • #791799
?:year
  • 2020

Metadata

Anon_0  
expand all